Functional impairment of CMV-reactive cellular immunity during pregnancy.
about
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patientsAn optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.
P2860
Functional impairment of CMV-reactive cellular immunity during pregnancy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Functional impairment of CMV-reactive cellular immunity during pregnancy.
@en
type
label
Functional impairment of CMV-reactive cellular immunity during pregnancy.
@en
prefLabel
Functional impairment of CMV-reactive cellular immunity during pregnancy.
@en
P2093
P2860
P356
P1476
Functional impairment of CMV-reactive cellular immunity during pregnancy.
@en
P2093
Anne Rascle
Birgit Seelbach-Goebel
Edith Reuschel
Florian Zeman
Hanna Bendfeldt
Ludwig Deml
Sascha Barabas
P2860
P304
P356
10.1002/JMV.24639
P577
2016-07-22T00:00:00Z